CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $89,000 | +64.8% | 177,115 | +839.3% | 0.00% | – |
| Q4 2017 | $54,000 | +68.8% | 18,857 | +66.3% | 0.00% | – |
| Q3 2017 | $32,000 | -25.6% | 11,336 | +5.7% | 0.00% | – |
| Q3 2016 | $43,000 | -71.7% | 10,723 | -73.3% | 0.00% | -100.0% |
| Q1 2016 | $152,000 | -95.3% | 40,161 | -80.5% | 0.00% | -95.0% |
| Q4 2015 | $3,233,000 | +593.8% | 206,213 | +1015.6% | 0.02% | +566.7% |
| Q2 2015 | $466,000 | -68.5% | 18,484 | -65.2% | 0.00% | -72.7% |
| Q1 2015 | $1,479,000 | +259.0% | 53,041 | +135.0% | 0.01% | +266.7% |
| Q4 2014 | $412,000 | – | 22,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |